Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Multani

Showing results (271-280 of 462) with videos related to

Pageof 47
Sort By:
Current Medical Research and Opinion|September 4, 2025
Patterns of healthcare visits and vaccination among adolescents and young adults 16-23-years-old: a retrospective US claims database analysisOscar Herrera-Restrepo, Jasjit K Multani, Zifan Zhou, et al.
The Prostate|August 12, 2006
Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasisJianchun Xu, Ruoxiang Wang, Zhi Hui Xie, et al.
International Journal of Cancer|January 16, 2013
RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesisGong Yang, Imelda Mercado-Uribe, Asha S Multani, et al.
Plos One|March 2, 2013
Dissociated primary human prostate cancer cells coinjected with the immortalized Hs5 bone marrow stromal cells generate undifferentiated tumors in NOD/SCID-γ miceXin Chen, Bigang Liu, Qiuhui Li, et al.
Future Oncology (London, England)|May 12, 2025
Impact of social determinants of health on treatment patterns and outcomes in multiple myelomaNatalie Boytsov, Jasjit K Multani, Zifan Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 11, 2024
Burden of Infection in Patients With and Without Secondary Immunodeficiency Disease Following Diagnosis of a Mature B Cell MalignancyJoshua Richter, Matthew S Davids, Colin Anderson-Smits, et al.
BMC Medical Education|May 29, 2026
Cooking with the curriculum: expanding nutrition knowledge in medical education through a longitudinal, peer teaching, culinary medicine modelAlyssa Tenney, Molly Hurd, Sarah Dr Krumholz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2017
Activity of Entrectinib in a Patient With the First Reported <i>NTRK</i> Fusion in Neuroendocrine CancerDarren Sigal, Marie Tartar, Marin Xavier, et al.
Diabetes, Obesity & Metabolism|March 10, 2022
Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin-treated type 2 diabetes: Results from a real-world nested case-control studyJulie Settles, Hong Kan, Christopher J Child, et al.
JCO Precision Oncology|September 11, 2020
Response to Entrectinib in Differentiated Thyroid Cancer With a <i>ROS1</i> FusionStephen V Liu, Laura A Macke, Bradley S Colton, et al.
Pageof 47

Showing results (271-280 of 462) with videos related to

Sort By:
Pageof 47
Current Medical Research and Opinion|September 4, 2025
Patterns of healthcare visits and vaccination among adolescents and young adults 16-23-years-old: a retrospective US claims database analysisOscar Herrera-Restrepo, Jasjit K Multani, Zifan Zhou, et al.
The Prostate|August 12, 2006
Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasisJianchun Xu, Ruoxiang Wang, Zhi Hui Xie, et al.
International Journal of Cancer|January 16, 2013
RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesisGong Yang, Imelda Mercado-Uribe, Asha S Multani, et al.
Plos One|March 2, 2013
Dissociated primary human prostate cancer cells coinjected with the immortalized Hs5 bone marrow stromal cells generate undifferentiated tumors in NOD/SCID-γ miceXin Chen, Bigang Liu, Qiuhui Li, et al.
Future Oncology (London, England)|May 12, 2025
Impact of social determinants of health on treatment patterns and outcomes in multiple myelomaNatalie Boytsov, Jasjit K Multani, Zifan Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 11, 2024
Burden of Infection in Patients With and Without Secondary Immunodeficiency Disease Following Diagnosis of a Mature B Cell MalignancyJoshua Richter, Matthew S Davids, Colin Anderson-Smits, et al.
BMC Medical Education|May 29, 2026
Cooking with the curriculum: expanding nutrition knowledge in medical education through a longitudinal, peer teaching, culinary medicine modelAlyssa Tenney, Molly Hurd, Sarah Dr Krumholz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2017
Activity of Entrectinib in a Patient With the First Reported <i>NTRK</i> Fusion in Neuroendocrine CancerDarren Sigal, Marie Tartar, Marin Xavier, et al.
Diabetes, Obesity & Metabolism|March 10, 2022
Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin-treated type 2 diabetes: Results from a real-world nested case-control studyJulie Settles, Hong Kan, Christopher J Child, et al.
JCO Precision Oncology|September 11, 2020
Response to Entrectinib in Differentiated Thyroid Cancer With a <i>ROS1</i> FusionStephen V Liu, Laura A Macke, Bradley S Colton, et al.
Pageof 47